Medicare Sequestration Will Harm Beneficiary Access Despite 2% Limit, Rep. Burgess Says
This article was originally published in The Pink Sheet Daily
Rep. Burgess sees little congressional enthusiasm for trying to avoid the across-the-board federal budget cuts, slated for March 1, as further budget battles loom on the horizon.
You may also be interested in...
House Speaker John Boehner made an offer to President Obama Dec. 3 to base a resolution to the looming fiscal cliff on a proposal by the president’s deficit commission headed by Erskine Bowles and Alan Simpson, a proposal that included a mandatory rebate on drugs used in Medicare Part D.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.